GSK said the U.S. Food and Drug Administration extended its review period for Blenrep combinations to treat patients with relapsed or refractory multiple myeloma.

DSHEA struck a balance between providing easy, affordable access to dietary supplements and maintaining safety and efficacy standards for drugs.

The Swiss company, which markets Elevidys abroad, said it believes the benefit-risk balance to treatment remains positive in ...

Last week, the Vapor Technology Association ran ads stating its opposition to illegally imported Chinese vapes, citing the risk they pose to children, despite its leadership and the organization ...

Medically reviewed by Brendan Camp, MD Silvadene (silver sulfadiazine) cream is a topical antibacterial drug used to treat or prevent bacterial infections associated with burns. It works against a ...

Two types of tuna sold in seven states are being recalled due to listeria concerns. The first recall affects tuna salad and ...

The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug Blenrep as a combination treatment, the company said on Wednesday.

Ticker: Americans putting money in investment income; FDA names former pharmaceutical company executive to oversee US drug ...

“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...

FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency’s ...

The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...

Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...